DMDeepinder Singh Malik

Deepinder Singh Malik

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Deepinder Singh Malik has a total of 37 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • India’s Cosmetic Revolution: Navigating Growth and Regulatory Transformations

    by Ravi Goyal, Abhay Asthana, Deepinder Singh Malik

    Background: The Indian cosmetic industry has witnessed rapid expansion due to urbanization, rising disposable incomes, and increasing demand for natural and cruelty-free products. This growth has driven the need for a well-defined regulatory framework. The Drugs and Cosmetics Act, 1940, along with oversight by the Central Drugs Standard Control Organization (CDSCO) and standards set by the Bureau of Indian Standards (BIS), forms the foundation of cosmetic regulation in India. The introduction of the Cosmetics Rules, 2020 has further strengthened the regulatory system by modernizing definitions, licensing procedures, and safety requirements. Purpose: This review aims to critically analyze the current regulatory framework governing the design, manufacturing, and distribution of cosmetics in India, with emphasis on recent amendments and their practical implications. Methods: A qualitative narrative review was conducted using secondary data sources, including regulatory documents, CDSCO guidelines, BIS standards, and relevant literature retrieved from PubMed, Scopus, and Google Scholar (2010–2025). Only studies relevant to cosmetic regulation were included. Results: The review identifies that the Cosmetics Rules, 2020 have significantly streamlined licensing procedures, introduced risk-based regulatory oversight, and improved alignment with international frameworks, particularly in areas of GMP compliance, labeling requirements, and import regulation. Conclusion: The updated regulatory framework has enhanced transparency, product safety, and quality assurance within the Indian cosmetic sector. Further alignment with global standards and supportive measures for industry stakeholders can strengthen regulatory effectiveness and promote sustainable growth.

  • Insight Review on Data Quality Management in Pharmacovigilance

    by Pallavi Bassi, Narinderpal Kaur, Shivani Rana, Anmoldeep Kaur, Deepinder Singh Malik

    Pharmacovigilance is the scientific system developed to ensure the overall safety of amedicinal product by precise collection, compilation, and assessment of adverse drug-relatedevents. The review focuses on the accurate evaluation of all the risk factors relevant to medicinalproduct use depending upon how precisely the adverse event data has been handled and processedto maintain by implementing quality standards at several stages, such as data entry, databaseselection, processing, and storage; this high-quality data can be obtained and maintained. Inaddition, the timeline in which data is received and reported to regulatory authorities is of vitalimportance. This review highlights key aspects of data quality management in pharmacovigilancefocusing on data processing, management and its designing, regulatory guidelines, timelinesfor reporting of safety data, and the periodic safety update report (PSUR) process. Furthermore,the importance of reference safety information (RSI) and pharmacovigilance duringhealthcare emergencies is also highlighted. The evolution of pharmacovigilance systems, drivenby automation and the WHO Drug Dictionary (WHO-DD) is examined, demonstrating how thesedevelopments enhance global safety monitoring, data accuracy, and reporting effectiveness.Therefore, for pharmacovigilance to ensure drug safety, high-quality data management is essential.Pharmacovigilance systems can be made more effective and efficient by utilizing digitaltools and real-world data via automation and future technological improvements that can simplifydata gathering and analysis.

  • Vesicular Nanocarriers: A Potential Platform for Topical/Transdermal Delivery of Antibiotics

    by Mohit Chadha, Deepinder Singh Malik

    Background: Bacterial infections are becoming difficult to treat nowadays due to the development of resistance towards conventional treatments. Conventional topical formulations loaded with antibiotics display various disadvantages, like high dosing frequency, high toxicity, and poor patient compliance. The former limitations may sometimes lead to severe complications and hospitalization of patients. However, these can be overcome by employing vesicular nanocarriers for the delivery of antibiotics following the topical/transdermal route. Objective: The objective of this review paper was to summarize the role of vesicular nanocarriers, like liposomes, elastic liposomes, niosomes, ethosomes, solid lipid nanoparticles, nanostructured lipid carriers, and nanoemulsions for topical/transdermal delivery of antibiotics, and patents associated with them. Methods: Literature for the present review was collected using various search engines, like PubMed, Google Scholar, and Google Patents. Results: Various literature investigations have revealed the in vitro and preclinical efficacy of vesicular nanocarrier systems in the delivery of antibiotics following the topical/transdermal route. Conclusion: Vesicular nanocarrier systems, via targeted delivery, may subside various side effects of antibiotics associated with conventional delivery, like high dosing frequency and poor patient compliance. However, their existence in the pharmaceutical market will be governed by effective clinical assessment and scale-up methodologies.


  • Formulation and evaluation of herbal essential oil based nail lacquer for management of onychomycosis

    by Ravi Goyal, Annima Goyal, Azmat Ali Khan, Sabiha Fatima, Tanveer Singh, Deepinder Singh Malik


  • Intranasal Route an Alternative Approach for Systemic Drug Delivery: Recent Strategies and Progression

    by Rajni Bala, Deepinder Singh Malik, Reecha Madaan, Shammy Jindal, Vimanpreet Kaur

    : Intranasal administration has proven to be a viable alternative for local and systemic delivery of varied therapeutic agents. This route has been potentially researched for delivering polar compounds, vaccines, hormones, peptides, proteins, etc. Being non-invasive and painless with a fast onset of action (both local and systemic), intranasal has become an ideal route for medication to children. This route is specifically employed for the delivery of drugs that are unstable in GIT, which gets significantly degraded or metabolized by the first-pass effect. The nasal route's high absorption and permeability profile has led to its exploration as a substitute for parenteral delivery. This paper reviews the feasibility and potentials of intranasal administration, discussing its benefits, drawbacks, market analysis, factors affecting nasal drug delivery system, conventional and novel strategies (polymeric and nano-carrier-based delivery systems) to improve nasal ab-sorption and its clinical management of varied systemic and topical disorders viz. neurodegenerative, pulmonary, microbial, neoplastic, etc.

  • Open Access

    Leucaena leucocephala succinate based polyelectrolyte complexes for colon delivery of synbiotic in management of inflammatory bowel disease

    by Gaganpreet Kaur, Aman Kumar, Samridhi Kurl, Neeraj Mittal, Deepinder Singh Malik, Pallavi Bassi, Tanveer Singh, Azmat Ali Khan, Amer M. Alanazi, Gurpreet Kaur


  • Cosmeceutical Aptitudes of Niacinamide: A Review

    by Piyush Madaan, Priyanshi Sikka, Deepinder Singh Malik

    Background: The prevalence and scope of dermatological illness differ from region to region. Based upon type and severity, the conditions may vary from superficial to deep systemic skin infections. Niacinamide, an amide analog of vitamin B3 which was conventionally utilized as a food supplement, is now explored for the management of skin disorders. Being a powerhouse on its own, it is not stored inside the body naturally and has to be acquired from external sources. Areas covered: This review is an attempt to disclose the physiology, pharmacology, and highlight the dermatological potentials of niacinamide, discussing its pharmacological mechanisms, varied commercially available treatments, and novel approaches, i.e., in research and patented formulations. Results: Niacinamide has been verified in treating almost every skin disorder, viz. aging, hyperpigmentation, acne, psoriasis, pruritus, dermatitis, fungal infections, epidermal melasma, non-melanoma skin cancer, etc. It has been reported to possess numerous properties, for instance, anti-inflammatory, antimicrobial, antioxidant, antipruritic, and anticancer, which makes it an ideal ingredient for varied dermal therapies. Long term use of niacinamide, regardless of the skin type, paves the way for new skin cells, makingskin healthier, brighter, and hydrated. Conclusion: Niacinamide possesses a variety of positive characteristics in the field of dermatology. Novel approaches are warranted over current treatments which could bypass the above shortcomings and form an effective and stable system. Hence, niacinamide has the potential to become an individual and a productive component with wide future scope.


  • Cosmeceutical Aptitudes of Azelaic Acid

    by Supriya Kumari Singh, Saumya Chaubey, Anil Bansal, Gurpreet Kaur, Deepinder Singh Malik

    Azelaic acid (AZA) is a white crystalline dicarboxylic acid naturally found in grains, rye, and barley. AZA has substantial biological and therapeutic abilities (viz a viz) its anti-inflammatory, anti-oxidant, anti-keratinizing, anti-microbial properties, etc., which contribute to its applicability in the management of mild to harsh dermatological complications (acne, rosacea, dermatitis, hyper-pigmentation, carcinomas, etc.). AZA has shown its effectiveness against varied non-inflammatory and inflammatory lesions by normalizing hyper-keratinization state and attenuating the increased levels of microbial content. Topically AZA, either alone or in conjunction with other active moieties, has proved to effectively prevent acne and several other hyper-pigmentary conditions. Chronic applicability of AZA has been evidenced with the effects like itching, burning, stinging, redness, etc. To deal with the former issues, research is being conducted to substitute the conventional formulations with novel preparations (liposome’s, niosomes, micro sponges, lipid nanocarriers, etc.), which could enhance the overall pharmaceutical and pharmacological profile of the drug. This article is an attempt to highlight the basic physiochemical properties of AZA, its physiological role (especially in dermatology), various commercial preparations and recent novel approaches that are in research with an aim to augment the therapeutic and safety profile of AZA.


  • Nanocarriers as Prospective Approach in Effective Management of Acne Vulgaris

    by Tanya Lugani, Manju Nagpal, Deepinder Singh Malik, Ameya Sharma, Vivek Puri, Gitika Arora Dhingra

    Acne is a chronic disease associated with the pilosebaceous unit and is affected by Propionibacterium acnes bacteria. Approximately 95% of people worldwide suffer from acne in their life span with a higher prevalence among teenagers (esp. boys). Conventional strategies incorporating antibiotics, steroids, hormones, etc. are recommended orally, systemically, or topically, employed for the treatment of acne but with various side effects (itching, scaling, redness, etc.) and are no more commercially accepted. The literature has been collected using various search engines google scholar, PubMed, science direct, etc. The review highlights the history of acne, its pathophysiology, developmental factors, various treatment evolutions strategies ranging from conventional to novel approach eradicating the secondary effects with enhanced efficacy and safety profile. We discussed various nanotechnological carriers (liposomes, niosomes, solid lipid nanoparticles, nanostructured lipid carriers, microsponges and other nanoscale formulations), which are formulated in the last decade for the effective treatment of acne. Patent literature and marketed formulations are included in the last sections. The encapsulation efficiency of anti-acne drugs in different nanocarriers improves the efficacy as well as minimizes the side effects of the drug. These carriers showed better bioavailability as well as better penetration effects even to the pilosebaceous unit of the skin. Tolerance can be improved by increasing the concentration of anti-acne drugs in the nano-carrier formulation. Conventional treatment strategies for acne had some limitations like scaling, itching, and inflammation which can be overcome by nano-formulations, which exhibit better efficacy. At present, various nano-technological carriers are being used potentially for the treatment of acne. These nano-formulations are also associated with some limitations like drug entrapment, stability issues, but these will be overcome in the upcoming years as long as the research is being continued in this area.

  • An Insight into the Dermatological Applications of Neem: A Review on Traditional and Modern Aspect

    by Varinder Singh, Meghaditya Roy, Nidhi Garg, Amit Kumar, Sandeep Arora, Deepinder Singh Malik

    Background : Dermatological disorders are cutaneous infirmities which are frequently occurring and increasing at an alarming rate. These range from mild itching/redness (dermatitis) to fatal skin cancers and has posed a major health concern. Azadirachta indica A. Juss (commonly known as neem), a member of Meliaceae family, is an Indian medicinal plant which has been known for its health promoting effects since ancient times. Objective: The review highlights the traditional practices, pharmacological aspects, and formulatory approach of neem for the treatment of dermatological disorders. Further, recent patents and novel delivery systems (developed and in pipeline) improving skin delivery and therapeutic profile of neem are discussed. Results : Neem is a traditional medicinal plant that has been employed for the prevention and treatment of numerous ailments covering systemic and topical disorders. Scientific studies have validated the traditional claims of neem and attributed these health benefits to the presence of more than 300 structurally diverse and complex compounds. It possesses anti-inflammatory, antibacterial, analgesic, antiviral, antifungal, immunomodulatory and antioxidant activities which substantiate its use as skin therapy. Various novel formulations and associated patents that improved the permeability of neem based products across skin could be found in literature. Conclusion : Critical appraisal of available literature revealed that neem possesses anti-microbial, anti-inflammatory, antioxidant and antiseptic properties. Thus it has the potential to be developed as a single effective therapy for the management of multimodal skin disorders. Further, pharmaceutical tailoring of neem by implication of novel carriers could enhance its penetrability across skin.